XERIS PHARMACEUTICALS INC Proceeds from Long-Term Debt Issued
XERIS PHARMACEUTICALS INC reported Proceeds from Long-Term Debt Issued of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $3.50M.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $11.25M, a 81.25% decline year-over-year.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2019-09-30 was $60.00M, a 300.00% increase year-over-year.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2020 was $94.84M, a 58.07% increase from fiscal 2019.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2019 was $60.00M, a 71.43% increase from fiscal 2018.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2018 was $35.00M.
- XERIS PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2017 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $14.75M derived: sum of 2 quarters · filed 2021-03-09 | $94.84M 10-K · filed 2021-03-09 | |
| 2020-09-30 | $11.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $91.34M 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $80.09M 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $60.00M derived: sum of 2 quarters · filed 2021-03-09 | $60.00M derived: sum of 3 quarters · filed 2021-03-09 | $60.00M 10-K · filed 2021-03-09 |
| 2019-09-30 | $60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $60.00M derived: sum of 2 quarters · filed 2020-11-09 | $60.00M 10-Q · filed 2020-11-09 | $60.00M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2020-08-10 | $15.00M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $15.00M derived: sum of 3 quarters · filed 2020-03-12 | $15.00M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $15.00M derived: sum of 2 quarters · filed 2020-03-12 | $15.00M derived: sum of 3 quarters · filed 2020-03-12 | $35.00M 10-K · filed 2020-03-12 |
| 2018-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $15.00M derived: sum of 2 quarters · filed 2019-11-07 | $35.00M 10-Q · filed 2019-11-07 | $35.00M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $20.00M 10-Q · filed 2019-08-06 | $20.00M derived: sum of 3 quarters · filed 2019-08-06 | $20.00M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $20.00M 10-Q · filed 2019-05-09 | $20.00M derived: sum of 2 quarters · filed 2019-05-09 | $20.00M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 |